May. 8 at 2:44 PM
The U.S. pharmaceutical company
$CRL soared +18.68% on Wednesday at
$136.97 & another 3% late morning Thursday at
$141.10, after lifting its full-year earnings guidance. Charles River now anticipates its adjusted earnings will range from
$9.30 to
$9.80 per share, compared to its earlier call for
$9.10 to
$9.60 a share. The stock is up +41.13% in the past month, but still down -23.59% in 2025 & -38.69% y/y, with a market cap of
$6.73B.